Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Nature

Volumn 469, Issue 7331, 2011, Pages 539-542

  Varela, Ignacio ^a   Tarpey, Patrick ^a   Raine, Keiran ^a   Huang, Dachuan ^b   Ong, Choon Kiat ^b   Stephens, Philip ^a   Davies, Helen ^a   Jones, David ^a   Lin, Meng Lay ^a   Teague, Jon ^a   Bignell, Graham ^a   Butler, Adam ^a   Cho, Juok ^a   Dalgliesh, Gillian L ^a   Galappaththige, Danushka ^a   Greenman, Chris ^a   Hardy, Claire ^a   Jia, Mingming ^a   Latimer, Calli ^a   Lau, King Wai ^a   Marshall, John ^a   McLaren, Stuart ^a   Menzies, Andrew ^a   Mudie, Laura ^a   Stebbings, Lucy ^a   Largaespada, David A ^c   Wessels, L F A ^d   Richard, Stephane ^e,f   Kahnoski, Richard J ^g   Anema, John ^g   A tuveson, David ^h   Perez Mancera, Pedro A ^h   Mustonen, Ville ^a   Fischer, Andrej ^a,i   Adams, David J ^a   Rust, Alistair ^a   Chan On, Waraporn ^b   Subimerb, Chutima ^b   Dykema, Karl ^j   Furge, Kyle ^j   Campbell, Peter J ^a   Teh, Bin Tean ^b,j,k   Stratton, Michael R ^a,l   Futreal, P Andrew ^a   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f BICÊTRE HOSPITAL   (France)

^g SPECTRUM HEALTH   (United States)

^h IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j VAN ANDEL RESEARCH INSTITUTE   (United States)

^k DUKE NUS MEDICAL SCHOOL   (Singapore)

^l INSTITUTE OF CANCER RESEARCH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CHROMOSOME; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; HISTOLOGY; MUTATION; POLYMERASE CHAIN REACTION; PROTEIN;

ARTICLE; CANCER GENETICS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; EXOME; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HUMAN; KIDNEY CARCINOMA; PBRM1 GENE; PRIORITY JOURNAL; SNF GENE; SWI GENE; TUMOR GENE;

EID: 79251635938     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature09639     Document Type: Article

References (30)

1. Van Haaften, G. et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nature Genet. 41, 521-523 (2009)
2. Dalgliesh, G. L. et al. Systematic sequencing of renal carcinomareveals inactivation of histone modifying genes. Nature 463, 360-363 (2010)
3. Kouzarides, T. Chromatin modifications and their function. Cell 128, 693-705 (2007)
4. Thompson, M. Polybromo-1: the chromatin targeting subunit of the PBAF complex. Biochimie 91, 309-319 (2009)
5. Gnirke, A. et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nature Biotechnol. 27, 182-189 (2009)
6. Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865-2871 (2009)
7. Reisman, D., Glaros, S. & Thompson, E. A. The SWI/SNF complex and cancer. Oncogene 28, 1653-1668 (2009)
8. Schneppenheim, R. et al. Germline nonsensemutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am. J. Hum. Genet. 86, 279-284 (2010)
9. Versteege, I. et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203-206 (1998)
10. Wong, A. K. C. et al. BRG1, A component of the SWI-SNF complex, Is mutated in multiple human tumor cell lines. Cancer Res. 60, 6171-6177 (2000)
11. Chandrasekaran, R. & Thompson, M. Polybromo-1-bromodomains bind histone H3 at specific acetyl-lysine positions. Biochem. Biophys. Res. Commun. 355, 661-666 (2007)
12. Xia, W. et al.BAF180is a critical regulator ofp21 induction and a tumor suppressor mutated in breast cancer. Cancer Res. 68, 1667-1674 (2008)
13. Sekine, I. et al. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer. Oncogene 24, 2735-2738 (2005)
14. Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806 (2008)
15. Keng, V. W. et al. A conditional transposon-based insertional mutagenesis screen for genes associated withmouse hepatocellular carcinoma. Nature Biotechnol. 27, 264-274 (2009)
16. Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450 (2003)
17. Starr, T. K. et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323, 1747-1750 (2009)
18. Burrows, A. E., Smogorzewska, A. & Elledge, S. J. Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc. Natl Acad. Sci. USA 107, 14280-14285 (2010)
19. Xue, Y. et al. The human SWI/SNF-B chromatin-remodeling complex is related to yeast Rsc and localizes at kinetochores of mitotic chromosomes. Proc. Natl Acad. Sci. USA 97, 13015-13020 (2000)
20. Vries, R. G. J. et al. Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev. 19, 665-670 (2005)
21. Mandriota, S. J. et al. HIF activation identifies early lesions inVHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 1, 459-468 (2002)
22. Young, A. P. et al. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nature Cell Biol. 10, 361-369 (2008)
23. Clifford, S. C., Prowse, A. H., Affara, N. A., Buys, C. H. C. M.& Maher, E. R. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHLindependent pathway in clear cell renal tumourigenesis. Genes Chromosom. Cancer 22, 200-209 (1998)
24. Kenneth, N. S., Mudie, S., Van Uden, P. & Rocha, S. SWI/SNF regulates the cellular response to hypoxia. J. Biol. Chem. 284, 4123-4131 (2009)
25. Wang, X. et al. Expression of p270 (ARID1A), A component of human SWI/SNF complexes, In human tumors. Int. J. Cancer 112, 636-642 (2004)
26. Jones, S. et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330, 228-231 (2010)
27. Wiegand, K. C. et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 363, 1532-1543 (2010)
28. Papaemmanuil, E. et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nature Genet. 41, 1006-1010 (2009)
29. Collier, L. S., Carlson, C. M., Ravimohan, S., Dupuy, A. J. & Largaespada, D. A. Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 436, 272-276 (2005)
30. Uren, A. G. et al. Large-scale mutagenesis in p19ARF-and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133, 727-741 (2008).